Skip to main content
. 2018 Apr 11;9:318. doi: 10.3389/fphar.2018.00318

FIGURE 1.

FIGURE 1

Bezafibrate (BF) ameliorates systolic function in TazKD mice. (A) Left ventricular ejection fraction. (B) Left ventricular fractional shortening. Asterisks denote significant differences between groups (p < 0.05).